ASM International NV (ASM.AMS) AI OPINIONS & ADVISOR ANALYSIS
Read the selected AI Advisor’s complete report, scenarios and forecast. Select Consensus for its investment thesis and a preview of advisor weights. Eligible access unlocks all 14 advisor reports and comparisons.
Updated on 5 October 2026Deep analysis 21 September 2026
Russlan Ramdowar
Opus 5Universal Investor AI
The Polymath FrameworkPrice-adjusted rating
Neutral
5-Year Return Est.
+36.2%
Includes 0.29% annual net dividend contribution
Historical prices and published forecast
- Observed price
- Published advisor forecast
Quarterly Events ForecastPrice targets, total returns and complete scenario reasoning
Forecast prices in EUR. Returns are cumulative from the forecast anchor. Swipe horizontally to read every column.
| Quarter | Forecast | Total return | Scenario |
|---|---|---|---|
| €863 | +6.0% | Q3 results in late October confirm roughly €1,100 million revenue and the guided H2 uplift above 20%, with first 1.4nm contribution. Recovery from September's rate-driven drawdown, tempered by a persistent 5% ten-year. | |
| €906 | +11.3% | Full-year 2026 results near €4.1 billion validate the raised 2027 floor above €4.6 billion. The €150 million buyback and CFO transition proceed smoothly; leading-edge order commentary sustains upward estimate revisions. | |
| €969 | +19.1% | SEMI's projected 21.8% WFE expansion in 2027 materialises through logic and HBM orders. Q1 revenue and margin beat consensus; molybdenum ALD share gains at 1.4nm become quantifiable in customer disclosures. | |
| €1,008 | +23.9% | Momentum persists but decelerates as the shares approach prior highs. Elevated positioning repeats the Q2 2026 pattern of selling on good news; inflation near 3% keeps European real yields restrictive. | |
| €947 | +16.4% | First credible 2028 digestion signals appear in customer capex plans. Order intake commentary softens while revenue still grows - the divergence that historically triggers de-rating in equipment names ahead of the print. | |
| €872 | +7.1% | 2028 guidance implies flat-to-lower revenue, validating Gartner's flagged cyclical pause. China mature-node weakness compounds; the multiple contracts faster than earnings as the secular narrative temporarily loses authority. | |
| €828 | +1.8% | Digestion deepens. Gross margin drifts toward the 51% guide as leading-edge mix normalises and Spares and Services becomes the visible growth line. Cash generation holds, limiting downside versus levered peers. | |
| €853 | +4.8% | Stabilisation begins as DRAM 4F-squared transition orders arrive, activating the quantified $400-450 million served-market increase. Buyback resumption at depressed prices provides support; investors reprice trough earnings. | |
| €904 | +11.1% | Recovery visibility improves into 2029. Memory and next-node logic bookings accelerate simultaneously, a combination ASM has not previously enjoyed. Easier monetary conditions, if inflation retreats toward target, lift duration-sensitive multiples. | |
| €958 | +17.8% | Full-year 2028 results prove the digestion was shallow, cash generation intact. Management provides updated multi-year targets; any upward reset of the stale €5.7 billion 2030 figure drives estimate upgrades. | |
| €1,006 | +23.6% | Revenue re-accelerates toward €5.5 billion annualised on combined logic and 4F-squared DRAM demand. Operating margin recovers above 31% as volume leverage returns across the fixed R&D and Scottsdale cost base. | |
| €1,047 | +28.6% | Steady compounding phase. Spares and Services on a larger installed base now materially dampens earnings volatility, supporting a modestly higher sustainable multiple than tool-only equipment peers command. | |
| €1,088 | +33.7% | Year-end positioning favours quality semiconductor capital equipment as the AI buildout enters its physical-infrastructure phase. Power and packaging constraints, not deposition capacity, become the industry bottleneck narrative. | |
| €1,121 | +37.8% | 2029 results confirm progress toward above €1 billion free cash flow. Growth moderates to mid-teens; the market begins discounting the maturity of the current node-transition cycle into 2031 pricing. | |
| €1,166 | +43.3% | The 2030 target year arrives with revenue comfortably above the original €5.7 billion floor, vindicating the content thesis. Operating margin above 30% meets the long-term commitment; incremental upside narrows. | |
| €1,119 | +37.5% | A mid-cycle pause: customers digest 1.4nm and sub-nanometre capacity additions before the next architecture. Modest estimate cuts and profit-taking after four years of gains produce a shallow correction. | |
| €1,153 | +41.7% | Stabilisation on early orders for the next logic architecture and successor DRAM cell designs. Balance-sheet strength again enables counter-cyclical R&D and buybacks while competitors retrench spending. | |
| €1,199 | +47.3% | Fresh multi-year targets frame the 2032-2035 opportunity. Chinese domestic ALD substitution is now a visible competitive factor, capping the multiple even as absolute earnings reach new records. | |
| €1,235 | +51.7% | Mature compounding. Earnings per share approaching €40 supports the price at roughly 30x, a materially lower multiple than 2026's 36.9x - the compression tax the base case anticipated throughout. | |
| €1,272 | +56.3% | Horizon close with the business substantially larger and the valuation more defensible. Cumulative five-year appreciation near 58% trails earnings growth precisely because de-rating absorbed part of the operating success. |
1. Investment Thesis — Base Case
The central tension is that ASM's business is getting structurally better while its share price depends on something it cannot control. Content per wafer rises with every node - $450-500 million of added served market at 1.4nm, $400-450 million from 4F-squared DRAM - and Spares and Services growing 34% converts installed base into annuity cash [2][6][7]. Against that, the shares carry a 36.9x trailing multiple and a 1.72% free-cash-flow yield into a 5% ten-year. The base case therefore delivers earnings compounding partly offset by multiple compression, punctuated by a 2028 digestion year, with the share price advancing meaningfully less than profits over five years.
- FY2026 revenue near €4.1 billion at 32% adjusted operating margin implies roughly €21 clean earnings per share.
- By 2031, €6.5-7.0 billion revenue supports about €40 per share at a de-rated 30x multiple.
- Cross-check: implied 2031 enterprise value near €62 billion, about 4.5x revenue - demanding but historically attainable.
2. Scenarios & Signals
2.1. Bull Case
The bull case activates when management concedes its own 2030 target is obsolete. If 1.4nm share gains and an early 4F-squared DRAM transition push 2028 revenue past €5.5 billion, the Investor Day target resets toward €7-8 billion, and the cyclical-pause narrative dies. That reframing converts ASM from equipment cyclical to secular content compounder, and the multiple stops compressing just as earnings inflect. A simultaneous easing cycle would compound the effect through the discount rate. Shares would substantially exceed €1,800 by 2031.
2.2. Bear Case
The bear case begins with financing, not demand. If AI infrastructure funding tightens in 2028-2029 - hyperscaler capex discipline meeting Oracle-style negative free cash flow and unresolved AI antitrust litigation - leading-edge and HBM orders fall within two quarters given ASM's short shipment cycle. Revenue drops 20-25% peak-to-trough, mix reverses toward dilutive mature nodes, and a 36.9x multiple compresses toward 20x on falling earnings. The two forces multiply. Shares could revisit the €460-550 range.
2.3. Behavioral Alpha Signals
Sentiment, repricing cycle, crowd narrative, catalyst, and macro alignment.Expected Volatility Regime
Greed and Fear Index
Cycle Position
Price action and thesis reinforcement are feeding each other.
What does Media Tell? (Crowd Consensus)
The consensus treats ASM as the purest listed play on atomic-layer deposition intensity - sixteen buys, an average €1,075 target, JPMorgan at €1,174 and Barclays at €1,200, all raised after the price moved [18][19]. The settled assumption is that gate-all-around content growth makes the cycle irrelevant. The anchoring bias is the €1,092.50 high: the 26% drawdown is read as a discount rather than a discount-rate repricing.
What Crowds Get Wrong? (Alpha/Value Gap)
Slight overpricing, but the misread is subtler than the level. The crowd underestimates two things it can verify: reported earnings quality and the company's own growth arithmetic. Trailing net income exceeds trailing operating income because the €181 million ASMPT impairment reversal and FX flatter the 36.9x P/E [7]; the 1.72% free-cash-flow yield is the honest anchor. Meanwhile management's ladder - €4.6 billion in 2027 to €5.7 billion by 2030 - implies roughly 7% compound growth, not the 12% the narrative assumes [4][6].
When will Value Gap Repricing Happen? (Repricing Catalyst)
The reconciling event is the 2027 full-year guidance or the next Investor Day: management must either raise the 2030 target or confirm a post-2027 deceleration. Watch the first quarter where order intake commentary softens while revenue still grows - that divergence, likely late 2027, starts the repricing.
How is Asset Influenced by Macro Regime?
The macro wind is crosswise. Demand is insulated
- AI leading-edge capex is a strategic, not rate-sensitive, budget - but valuation is acutely exposed: at a 1.72% free-cash-flow yield against a 5.0% US 10-year and a Fed at 3.75-4.00%, every basis point of term premium is a direct multiple tax. A genuine disinflation turn would be worth more to this share price than another revenue beat.
3. Positive & Negative Factors, Risks & Opportunities
3.1. Base-Case Forces
Near-certain positive forces
Top Drivers / Tailwinds
Structural or operating forces that support this advisor thesis. These forces are treated as part of the base case (more than 60% probability of occurrence).
Scroll to view all columns
| Driver / Tailwind | Category | Est. stock-price impact | Est. earnings impact | Why it matters |
|---|---|---|---|---|
| Content PER Wafer Beats Wafer Count | Innovation And Product | +45% | +60% | ASM's revenue rises with node complexity, not with wafer volume. Management quantifies a $450-500 million served-market increase at 1.4nm gate-all-around and $400-450 million from DRAM's 4F-squared shift beginning 2028, both at 100k wafer starts [6][7]. The first meaningful 1.4nm contribution landed in H2 2026, with molybdenum ALD wins corroborating genuine share gain [8]. Content growth compounds through unit cycles. |
| THE WFE Forecast THAT Doubled | Sector And Industry | +30% | +38% | SEMI revised 2026 wafer-fab equipment to $143.9 billion, up 23.1%, then +21.8% in 2027 and +14.1% in 2028 - a violent upgrade from December 2025's +9.0% view [13][14]. ASM guides H2 2026 revenue over 20% above H1 and 2027 above the €4.6 billion top end of its prior range [1][4]. AI logic and HBM DRAM drive it; persistence depends on hyperscaler funding. |
| THE Quiet Annuity Inside A Cyclical | Operational Efficiency | +16% | +18% | Adjusted operating margin reached 33.0% in Q2 2026, level with the prior record, on 51.9% gross margin and disciplined SG&A below 8.5% of sales [1]. The under-discussed engine is Spares and Services, up 34% year on year - an installed-base annuity converting past tool shipments into recurring, higher-visibility cash [2]. This mix structurally dampens cyclical earnings amplitude and supports valuation through digestion years. |
| Unlevered IN A 4% World | Capital Allocation | +9.0% | +6.0% | ASM carries debt-to-equity of 0.02 and closed Q2 2026 with €1.2 billion cash after record €355 million quarterly free cash flow [2]. That self-funds Scottsdale capacity, R&D near 12.6% of revenue, a planned €150 million H2 2026 buyback and a rising dividend without dilution. With the Fed at 3.75-4.00%, financing-cost immunity is itself a competitive weapon when levered rivals retrench. |
Near-certain negative forces
Top Frictions / Headwinds
Expected frictions that can slow, cap, or damage this advisor thesis. These forces are treated as part of the base case (more than 60% probability of occurrence).
Scroll to view all columns
| Friction / Headwind | Category | Est. stock-price impact | Est. earnings impact | Why it matters |
|---|---|---|---|---|
| Discount RATE EATS THE Multiple | Macroeconomic And Macrofinancial | -32% | +0.0% | September's de-rating was arithmetic, not disappointment: shares sit roughly 26% below the €1,092.50 high while estimates were revised upward [16][18]. With the Fed at 3.75-4.00%, the US 10-year near 5.0% and the ECB at 2.50%, a 36.9x trailing multiple and 1.72% free-cash-flow yield leave no discount-rate cushion. Long-duration compounders compress first when real yields refuse to fall. |
| THE 2030 Target THAT DOES NOT ADD UP | Sector And Industry | -20% | -14% | Run management's own ladder: roughly €4.1 billion in 2026, above €4.6 billion in 2027, above €5.7 billion by 2030 implies barely 7% compound growth after 2027 against a claimed 12%-plus [1][4][6]. Either the target is stale or 2028-2030 embeds a pause; Gartner independently flags the next cyclical pause in 2028 [21]. Digestion years compress earnings and the multiple together. |
| China TAIL Shortens BY Decree | Political And Geopolitical | -13% | -11% | Mature logic/foundry is already guided down and is first-half weighted, with management warning that China could weaken further on policy developments [1][4][9]. The peer analogue is quantified: Applied Materials said trade rules hit roughly 10% of its China market in fiscal 2024 and more than double that in fiscal 2025, with China revenue falling from near 40% to the mid-20s [15]. Dutch alignment with tightening US controls is the transmission channel. |
| FIVE Customers HOLD THE PEN | Competitive Positioning | -9.0% | -7.0% | The top five customers account for 53% of revenue [22]. That hands TSMC, Samsung, Intel-class logic buyers and two memory makers structural pricing leverage precisely when ASM needs volume, and makes one customer's capex deferral a guidance event. Management separately named supply-chain pressure and cost inflation as live risks [8][10]. Concentration structurally caps the multiple even as technology wins accumulate. |
3.2. Risks & Opportunities
Plausible downside scenarios
Tail Risks
Less likely downside scenarios that could materially hurt the outcome if they occur.
Scroll to view all columns
| Tail scenario | Chance of Occurring | Stock Price Impact | Why plausible / what changes |
|---|---|---|---|
| AI Capex AIR Pocket | 30% | -38% | The upcycle rests on financing, not just demand. Anthropic and OpenAI need enormous external capital, Oracle already reported negative $5 billion free cash flow against $664 billion of remaining performance obligations, and September's antitrust complaint plus safety-slowdown rhetoric added legal uncertainty. A 2028-2029 funding squeeze would cut leading-edge and HBM order intake within two quarters, given ASM's short book-to-ship cycle. Revenue could fall 20-25% peak-to-trough and the multiple would compress toward 20x simultaneously. Below 50% because sovereign and hyperscaler balance sheets remain deep. |
| THE Hague Joins Washington Fully | 22% | -26% | A Dutch decision to align export licensing comprehensively with US controls - plausible around any 2027-2028 escalation following the September 2026 rare-earth shipment friction - would remove ASM's remaining mature-node China revenue and invite Chinese retaliation through component and rare-earth channels. Management named new US export controls as its primary risk factor [10]. The earnings hit would be immediate and the political-dependency discount permanent, since domestic Chinese ALD substitution accelerates under restriction. Below 50% because Dutch policy has so far preserved partial access. |
Plausible upside scenarios
Tail Opportunities
Less likely upside scenarios that could materially improve the outcome if they occur.
Scroll to view all columns
| Tail scenario | Chance of Occurring | Stock Price Impact | Why plausible / what changes |
|---|---|---|---|
| DRAM 4f Squared Arrives Early | 27% | +44% | ASM quantified a $400-450 million served-market increase from DRAM's 4F-squared transition starting 2028 [7]. If HBM capacity shortages pull that architecture forward into late 2027, and the recent Epi win at an additional DRAM customer converts into multi-fab qualification [1], memory could become a second leading-edge engine rather than a cyclical afterthought. Revenue would overshoot €5.5 billion by 2028 with mix-driven gross margin above the 51% guide. Probability stays modest because memory roadmaps historically slip rather than accelerate. |
| Investor DAY Resets THE 2030 BAR | 38% | +34% | The most probable re-rating trigger is management admitting its own target is stale. With 2027 already guided above €4.6 billion and 2030 still pegged at above €5.7 billion, an Investor Day in 2027 or 2028 - plausibly framed by incoming CFO Chris Figee, joining December 2026 [11] - could lift the 2030 revenue target toward €7-8 billion with operating margin above 32%. That reframes ASM from cyclical toolmaker to structural content compounder and justifies a durable premium multiple. It stays below 50% because a 2028 pause could arrive first. |
5. References & Context
Search behavior, retained evidence, supplied context, and response token details.External web search was used. The retained search terms and consulted sources are shown below.
Context supplied to the model
Public-safe inputs retained with this immutable forecast publication.
- 01
Market data
inmemory_base_placeholders__latest_eod_close_price_with_stats_and_fundamentals__var1
- 02
Global context in this run
Used
- 03
Fundamental data in this run
Used
- 04
Global context
Standard global market and cross-asset context
- 05
Subject context
Equity-specific subject and market context
- 06
Task framework
Standard investment-forecast task guidelines
- 07
Advisor framework
Universal Investor The Polymath
- 08
Forecast output requested
Equity Extended Investment Thesis (4 Quadrants and Alpha Asymmetry) + Pct Change Timeseries for Close Price with Rationale, (5Y Quarterly)
Global context snapshot
2026 Year-to-Date Global Market and World-Events Context Through September 20
Download Archived SnapshotCoverage 2026-01-01 to 2026-09-20 · Knowledge cutoff 2026-09-20
January 1-September 20, 2026: monetary tightening, energy security, trade restrictions, AI financing and divergent growth; five leading market themes.
Fed raised rates to 3.75%-4.00%; ECB hike is in force and BOJ increase starts September 24. Markets through September 18, bitcoin through September 19.
| Top 3 Market Shifts From File | Date | Status |
|---|---|---|
| Renewed monetary tightening amid persistent inflation | 2026-01-30 | ACTIVE POLICY REGIME |
| Iran/Hormuz conflict and wider energy-security disruption | 2026-02-28 | ONGOING |
| Tariff legal reset and strategic supply restrictions | 2026-02-20 | ACTIVE POLICY REGIME |
Representative Sources of the Context File
And more sources from the retained context package.
Fundamental context
Income statement
9 fieldsdepreciationAndAmortization · ebit · ebitda · grossProfit · +5 more fields
Balance sheet
11 fieldscash · commonStockSharesOutstanding · netDebt · netReceivables · +7 more fields
Cash flow
5 fieldscapitalExpenditures · dividendsPaid · freeCashFlow · salePurchaseOfStock · +1 more field
annual: 2014-12-31–2025-12-31, 12 periods; quarterly: 2023-09-30–2026-06-30, 12 periods
Currencies cited: EUR, USD (quote EUR; primary reporting EUR; converted/valuation USD).
Search terms retained
- 1.ASM International Q2 2026 results order intake guidance
- 2.ASM International 2026 revenue outlook second half
- 3.ASM International Investor Day 2030 revenue target €6-8 billion operating margin
- 4.ASM International share price September 2026 ASMPT stake analysts
- 5.wafer fab equipment spending 2027 forecast China export controls semiconductor equipment September 2026
Sources retained for this advisor
- [1]ASM reports second quarter 2026 resultsglobenewswire.com
- [2]ASMXF Q2 FY2026 earnings call — BigGo Financefinance.biggo.com
- [3]Almere, The Netherlands July 28, 2026, 6 p.m. CETasm.com
- [4]Earnings call transcript: ASM International posts record q2 2026 revenue, stock falls By Investing.cominvesting.com
- [5]ASM Q2 2026 slides: record revenue tops €1B, 2027 outlook raised By Investing.cominvesting.com
- [6]ASM hosts Investor Day, provides new 2030 targets, revises H2 2025 outlookglobenewswire.com
- [7]ASM reports third quarter 2025 resultsasm.com
- [8]ASM reports second quarter 2026 results | Nasdaqnasdaq.com
- [9]Asm International Signals Robust 2026 Earnings Momentum - TipRanks.comtipranks.com
- [10]ASMIY Q2 FY2026 earnings call — BigGo Financefinance.biggo.com
- [11]ASM reports second quarter 2026 results | The Manila Timesmanilatimes.net
- [12]ASM International (ENXTAM:ASM) Stock Forecast & Analyst Predictions - Simply Wall Stsimplywall.st
- [13]Global Semiconductor Equipment Sales Forecast to Reach a Record $229 Billion in 2028, SEMI Reports | SEMIsemi.org
- [14]What’s The Outlook For The Semi Equipment Biz in '26?marklapedus.substack.com
- [15][News] Applied Materials Flags a 2026 China Fab Spending Drop Amid Tougher U.S. Export Rulestrendforce.com
- [16]ASM Stock Price Today | AS: ASMI Live - Investing.cominvesting.com
- [17]ASM stock heads into the open after a 2.49% gainad-hoc-news.de
- [18]ASM (ASMI) Stock Forecast & Price Target - Investing.cominvesting.com
- [19]ASM International NV (AMS:ASM) Stock Price & Overviewstockanalysis.com
- [20]Investors | ASMasm.com
- [21]Forecast: Semiconductor Capital Spending, Wafer Fab Equipment and Capacity, Worldwide, 3Q25 Updategartner.com
- [22]ASM International (ASM) Investor Relations, Earnings Summary & Outlookquartr.com
Original published forecast
Inspect the original revision and sealed receipt when a public record is available. Integrity verification is separate from forecast accuracy.
Consensus Investment Thesis
Consensus Thesis Takeaway
Shared synthesis across the 14 advisor forecasts in this analysis.
ASM International NV occupies an indispensable monopolistic chokepoint in semiconductor fabrication as sub-2nm Gate-All-Around architectures, backside power delivery, and vertical 3D DRAM mandate atomic-scale monolayer precision. Controlling over 55% of single-wafer ALD, the company extracts structural content growth per wafer, expanding its served addressable market by more than $400 million per 100k monthly wafer starts. However, trading near 37 times trailing earnings against 5.0% sovereign bond yields, valuation provides minimal margin of safety. While operational compounding remains formidable, secular earnings expansion will be partially counterbalanced by terminal multiple compression toward historical norms of 26 to 28 times earnings.
- Operating leverage converts 11% top-line compounding into resilient free cash flow, yet terminal multiple de-rating caps total shareholder returns.
- Capitalized R&D and non-operating associate revaluations artificially flatter headline earnings, making organic cash conversion the decisive valuation anchor.
- Geopolitical export controls permanently restrict Chinese trailing-edge revenue, necessitating complete reliance on Western leading-edge fab execution to offset regional headwinds.
Advisor Disagreement
Where the Advisors Differ
The primary disagreement across reports centers on valuation elasticity and through-cycle multiples rather than operational technology leadership. Bullish perspectives argue that indispensable monopolistic chokepoints in 2nm nanosheets and backside power delivery justify sustaining price-to-earnings multiples above 32 times, generating substantial equity appreciation. Conversely, conservative and contrarian frameworks demonstrate that trading at 37 times earnings in a 5% sovereign bond yield environment mathematically forces multiple compression toward 24 to 26 times, offsetting operating compounding. This debate will be resolved by monitoring whether 2027 book-to-bill ratios sustain above parity and whether organic cash conversion matches reported operating income.
Behind the synthesis
How each opinion shapes the consensus
The analysis reveals strong independent evidence supporting structural wafer content expansion as leading logic foundries transition to Gate-All-Around architectures and backside power delivery. However, reports naively extrapolating trailing multiples above 36 times earnings rely on correlated assumptions of frictionless hyperscaler capex and permanent 52% gross margins. Rigorous verification from statutory interim filings and primary transcripts indicates that reported net earnings were flattered by non-operating associate impairment reversals, while trailing-edge Chinese equipment sales face structural normalization under expanding multilateral dual-use licensing curbs. The strongest credible contrarian insight confirms that elevated 5% sovereign bond yields exert persistent valuation gravity, meaning fundamental double-digit operating earnings growth will be partially absorbed by multiple contraction toward historical mid-cycle norms. Consequently, relative weighting prioritizes empirically grounded analyses that adjust for capitalized development, normalize earnings quality, and account for inevitable mid-cycle customer tool digestion.
Universal Investor AI
The Polymath
GPT-6 AstraExemplary empirical rigor incorporating primary statutory filings, statutory interim reports, and regulatory dual-use control lists. It accurately reconciles non-operating ASMPT impairment reversals and capitalized R&D cash outflows, establishing the most defensible through-cycle financial baseline.
Universal Investor AI
The Polymath
Opus 5Integrates authoritative primary earnings transcripts, SEMI equipment forecasts, and management's long-term target arithmetic. It persuasively reconciles structural layer-intensity expansion against cyclical digestion pauses and realistic post-2027 deceleration.
Universal Investor AI
The Polymath
Gemini 3.8 FlashAnchored by primary industry source verification, this assessment incorporates both leading-edge logic market-share expansion and memory DRAM optionality. It balances realistic multiple compression against verifiable technology adoption milestones across foundries.
Sherlock Holmes AI
The Whistleblower
Gemini 3.8 FlashPresents rigorous forensic accounting dissecting customer installation timing, capitalized cleanroom investments, and operational leverage across 2nm transitions. The thesis balances structural ALD growth against multiple compression from higher discount rates, maintaining consistent causal discipline.
Ray Dalio AI
The Strategist
Gemini 3.8 FlashDelivers a robust macroeconomic debt-cycle framework, correctly demonstrating how elevated sovereign bond yields mathematically de-rate premium growth multiples despite 12% operational earnings compounding. Its thorough examination of customer concentration and capex cyclicality provides essential risk-weighting balance.
Warren Buffett AI
The Value Seeker
Gemini 3.8 FlashProvides sound owner-earnings analysis and recognizes the durable tollbooth moat in atomic layer deposition. However, its valuation assumptions duplicate other value-oriented reports while slightly underestimating secondary demand acceleration from 3D DRAM transitions.
Warren Buffett AI
The Value Seeker
Gemini 3.8 FlashOffers prudent capital-allocation scrutiny, emphasizing the lack of margin of safety at a thirty-seven times earnings multiple. The report thoughtfully tracks high-margin spares compounding, though its quarterly path exhibits somewhat exaggerated cyclical volatility.
Explore every advisor’s contribution
You’re viewing 7 of 14 advisor weights. Sign in to check access to all explanations, complete advisor reports and comparisons.